EquitAI LogoEquitAI
$59.01
-0.20%
EXEL

EXEL

Exelixis, Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
3/10
Quality
10/10
Growth
6/10
Strength
3/10
Dividend
1/10
Price Trend
Upwards
Momentum
Stretched
Balance Sheet
High Leverage
Earnings
Growth
Dividend Yield
0.00%
Market Cap
$14.62B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Exelixis is a biotechnology company that focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers. Its primary business revolves around selling its approved cancer treatments to healthcare providers and funding clinical trials for future therapies. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...